Section 151.38 — Embargoes.
151.38 EMBARGOES. (1) Whenever a duly authorized agent of the board finds or has probable cause to believe that any drug or medicine is adulterated, or so misbranded as to be dangerous or fraudulent, or is being sold, delivered, or offered for sale in violation of section 151.361, the agent shall affix thereto an appropriate […]
Section 151.39 — Distressed Drugs.
151.39 DISTRESSED DRUGS. Subdivision 1. Definition. Distressed drugs shall mean drugs or medicines which have been subjected to accident, fire, flood, adverse temperatures, or other physical influences which could affect the potency, quality, purity, or efficacy of such drug or medicine could otherwise cause the drug or medicine to be adulterated or misbranded within the […]
Section 151.40 — Possession And Sale Of Hypodermic Syringes And Needles.
151.40 POSSESSION AND SALE OF HYPODERMIC SYRINGES AND NEEDLES. Subdivision 1. Generally. It is unlawful for any person to possess, control, manufacture, sell, furnish, dispense, or otherwise dispose of hypodermic syringes or needles or any instrument or implement which can be adapted for subcutaneous injections, except for: (1) the following persons when acting in the […]
Section 151.361 — Manufacturer Disclosure.
151.361 MANUFACTURER DISCLOSURE. Subdivision 1. After January 1, 1976. The manufacturer, packager, or distributor of any human use legend drug sold, delivered, or offered for sale in the state of Minnesota after January 1, 1976 must have printed on the label on the immediate container of the drug the name and address of the manufacturer […]
Section 151.37 — Legend Drugs; Who May Prescribe, Possess.
151.37 LEGEND DRUGS; WHO MAY PRESCRIBE, POSSESS. Subdivision 1. Prohibition. Except as otherwise provided in this chapter, it shall be unlawful for any person to have in possession, or to sell, give away, barter, exchange, or distribute a legend drug. Subd. 2. Prescribing and filing. (a) A licensed practitioner in the course of professional practice […]
Section 151.375 — Investigational Drug Use.
151.375 INVESTIGATIONAL DRUG USE. Subdivision 1. Title; citation. This section may be cited as the “Right to Try Act.” Subd. 2. Definitions. (a) For the purposes of this section, the following terms have the meanings given them. (b) “Eligible patient” means a patient who meets the requirements in subdivision 3. (c) “Investigational drug, biological product, […]
Section 151.302 — Immunity.
151.302 IMMUNITY. Members of the board and persons employed by the board or engaged in maintaining records and making reports regarding adverse health care events are immune from civil liability and criminal prosecution for any actions, transactions, or publications in the execution of or relating to their duties under section 151.301. History: 2004 c 186 […]
Section 151.32 — Citation.
151.32 CITATION. The title of sections 151.01 to 151.58 shall be the Pharmacy Practice and Wholesale Distribution Act. History: (5808-35) 1937 c 354 s 35; 1988 c 550 s 17; 2017 c 40 art 1 s 40; 1Sp2019 c 9 art 10 s 40
Section 151.33 — Careless Distribution Of Drugs.
151.33 CARELESS DISTRIBUTION OF DRUGS. Subdivision 1. Prohibited. No person, directly or indirectly, by agent or otherwise, shall scatter, distribute, or give away any samples of any medicine, drugs, or medical compounds, salve, or liniment of any kind unless the same is delivered into the hands of an adult person, or mailed to such persons […]
Section 151.335 — Delivery Through Common Carrier; Compliance With Temperature Requirements.
151.335 DELIVERY THROUGH COMMON CARRIER; COMPLIANCE WITH TEMPERATURE REQUIREMENTS. In addition to complying with the requirements of Minnesota Rules, part 6800.3000, a mail order or specialty pharmacy that employs the United States Postal Service or other common carrier to deliver a filled prescription directly to a patient must ensure that the drug is delivered in […]